Cardiovascular risk factor progression in young males at 15-year follow-up in the General Military Academy of Zaragoza (AGEMZA) study;Evolución de los factores de riesgo cardiovascular en jóvenes varones tras 15 años de seguimiento en el estudio Academia General Militar de Zaragoza (AGEMZA)

Revista Espanola de Cardiologia

Volumn 59, Issue 7, 2006, Pages 671-678

  Laclaustra Gimeno, Martín ^a   González García, Marí P ^a   Casasnovas Lenguas, José Antonio ^a,b   Luengo Fernández, Emilio ^a   León Latre, Montserrat ^a   Portero Pérez, Pilar ^a   del Rio Ligorit, Alfonso ^a   Giner Soria, Armando ^a   Ferreira Montero, Ignacio J ^a  

^a INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^b NONE   (Spain)

Author keywords

Cardiovascular risk factors; Cholesterol; Cohort; Hypertension; Lipids

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGING; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DATA COLLECTION METHOD; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OCCUPATIONAL DISEASE; OCCUPATIONAL HAZARD; OCCUPATIONAL HEALTH; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; SMOKING; SOLDIER; STATISTICAL MODEL; TIME SERIES ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

EID: 33748447836     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13091368     Document Type: Article

References (34)

1. Brotons Cuixart C, Ribera Solé A. Factores de riesgo cardiovascular en niños y adolescentes españoles. En: Plaza Pérez I, editor. Libro de la Sección de Cardiología Preventiva y Rehabilitación. Barcelona: Ediciones Doyma; 2000. p. 29-38.
2. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002;106:388-91.
3. Puzo Foncillas J, Casasnovas Lenguas JA, Celma Delgado MT, Giner Soria A, Garza Benito F, Lapetra Labe A, et al. Patrón lipídico en una población juvenil sana. An Med Interna. 1985;2: 205-8.
4. Puzo J, Casasnovas JA, Lapetra A, Garza F, Mas M, Del Río A, et al. Estudio de los parámetros lipídicos de dos poblaciones juveniles con diferente actividad física. Rev Clin Esp. 1988;182: 124-6.
5. Casasnovas JA, Puzo J, Garza F, Lapetra A, Elosegui LM, Del Río A, et al. Hematological indices as markers of ischemic heart disease in young smokers. Biomed Pharmacother. 1988;42:99-100.
6. Casasnovas JA, Lapetra A, Puzo J, Pelegrin J, Hermosilla T, De Vicente J, et al. Tobacco, physical exercise and lipid profile. Eur Heart J. 1992;13:440-5.
7. Casasnovas Lenguas JA, Crussells Canales MJ, Pelegrin Diaz J, Ferreira Aguar A, Serrano Aisa PJ, Del Río Ligorit A, et al. Cambios en el perfil lipídico de individuos jóvenes tras la sustitución del aceite de girasol de su dieta por aceite de oliva. Rev Esp Cardiol. 1997;50:843-50.
8. Repara F, Chueca M, Elcarte R, Inigo J, Oyarzabal M, Villa I. Obesidad infantil en Navarra: evolución, tendencia y relación entre obesidad infantil y adulta. Estudio PECNA. An Sist Sanit Navar. 1998;21:293-300.
9. Reparaz F, Elcarte R, Inigo J, Barriuso L, Villa I. Perfil lipídico: evolución, tendencia y seguimiento desde la infancia a la edad adulta. Estudio Pecna. An Sist Sanit Navar. 1998; 21:155-65.
10. Twisk JW, Kemper HC, Van Mechelen W, Post GB. Tracking of risk factors for coronary heart disease over a 14-year period: a comparison between lifestyle and biologic risk factors with data from the Amsterdam Growth and Health Study. Am J Epidemiol. 1997;145:888-98.
11. Ferreira I, Twisk JW, Van Mechelen W, Kemper HC, Stehouwer CD. Development of fatness, fitness, and lifestyle from adolescence to the age of 36 years: determinants of the metabolic syndrome in young adults: the Amsterdam growth and health longitudinal study. Arch Intern Med. 2005;165:42-8.
12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18:499-502.
13. Alastrue Vidal A, Rull Lluch M, Camps Ausas I, Ginesta Nus C, Melus Moreno MR, Salva Lacombe JA. Nuevas normas y consejos en la valoración de los parámetros antropométricos en nuestra población: índice adiposo muscular, índices ponderales y tablas de percentiles de los datos antropométricos útiles en una valoración nutricional. Med Clin (Barc). 1988;91:223-36.
14. a ed. Barcelona: Harcourt; 2000. p. 2234-71.
15. National Institutes of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults- he Evidence Report. Obes Res. 1998;6 Suppl 2:51-209.
16. Civeira F, Pocoví M, Moreda A, Alamillo JA, Cía P, Grande F. Niveles de colesterol y triglicéridos y distfibución del colesterol en lipoproteínas en una población laboral. Varones (I). Clin Invest Arterioscler. 1990;2:43-7.
17. Wilson PW, Anderson KM, Harris T, Kannel WB, Castelli WP. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol. 1994;49:M252-7.
18. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.
19. Wilsgaard T, Jacobsen BK, Schirmer H, Thune I, Lochen ML, Njolstad I, et al. Tracking of cardiovascular risk factors: the Tromso study, 1979-1995. Am J Epidemiol. 2001;154:418-26.
20. Twisk JW, Kemper HC, Mellenbergh GJ. Mathematical and analytical aspects of tracking. Epidemiol Rev. 1994;16:165-83.
21. Ulmer H, Kelleher C, Diem G, Concin H. Long-term tracking of cardiovascular risk factors among men and women in a large population-based health system: the Vorarlberg Health Monitoring & Promotion Programme. Eur Heart J. 2003;24:1004-13.
22. Twisk JW, Kemper HC, Mellenbergh GJ, Van Mechelen W. Relation between the longitudinal development of lipoprotein levels and biological parameters during adolescence and young adulthood in Amsterdam, The Netherlands. J Epidemiol Community Health. 1996;50:505-11.
23. Ortlepp JR, Metrikat J, Albrecht M, Maya-Pelzer P, Pongratz H, Hoffmann R. Relation of body mass index, physical fitness, and the cardiovascular risk profile in 3,127 young normal weight men with an apparently optimal lifestyle. Int J Obes Relat Metab Disord. 2003;27:979-82.
24. Laclaustra Gimeno M, González Garcia P, Serrano Aísa PJ, Lacambra Blasco I, Luengo Fernández E, Puzo Foncillas J, et al. Estudio AGEMZA: los cambios lipídicos en el adulto joven se relacionan con las medidas ponderales y sus modificaciones [abstract]. Rev Esp Cardiol. 2002;55 Supl 2:81.
25. Laclaustra Gimeno M, Portero Pérez MP, González García P, Del Río Ligorit A, González Carretero M, Casasnovas Lenguas JA, et al. Estudio AGEMZA: la tensión arterial del adulto joven depende de los cambios en su peso a partir de la adolescencia [abstract]. Rev Esp Cardiol. 2002;55 Supl 2:110.
26. Twisk JW, Kemper HC, Mellenbergh DJ, Van Mechelen W. Factors influencing tracking of cholesterol and high-density lipoprotein: the Amsterdam Growth and Health Study. Prev Med. 1996; 25:355-64.
27. Meigs JB, D'Agostino RB Sr, Wilson PW, Cupples LA, Nathan DM, Singer DE. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes. 1997;46:1594-600.
28. Criqui MH, Wallace RB, Heiss G, Mishkel M, Schonfeld G, Jones GT. Cigarette smoking and plasma high-density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence Study. Circulation. 1980;62 Suppl IV:70-6.
29. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet. 1992;339:1128-30.
30. Brischetto CS, Connor WE, Connor SL, Matarazzo JD. Plasma lipid and lipoprotein profiles of cigarette smokers from randomly selected families: enhancement of hyperlipidemia and depression of high-density lipoprotein. Am J Cardiol. 1983;52:675-80.
31. Cluette-Brown J, Mulligan J, Doyle K, Hagan S, Osmolski T, Hojnacki J. Oral nicotine induces an atherogenic lipoprotein profile. Proc Soc Exp Biol Med. 1986;182:409-13.
32. Mjos OD. Lipid effects of smoking. Am Heart J. 1988;115:272-5.
33. Puzo J, Casasnovas JA, Lapetra A, Garza F, Mas M, Del Río A, et al. Tabaquismo y lípidos. Estudio sobre una población juvenil, deportista y sana (primer informe). An Med Interna. 1988; 5:333-8.
34. De Souza LJ, Souto Filho JT, De Souza TF, Reis AF, Gicovate Neto C, Bastos DA, et al. Prevalence of dyslipidemia and risk factors in Campos dos Goytacazes, in the Brazilian state of Rio de Janeiro. Arq Bras Cardiol. 2003;81:249-64